Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025IAR Journal of Anaesthesiology and Critical Care

Corticosteroidal Clinical Efficacy in Combating Cytokine Storm in Hospitalized COVID-19 Infected Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

AHAdnan Aref Mosleh HasanMAMohammad Nayef Mufleh Al-QatarnehRARami Farah Mfadi Alrabadi

Discussion

Loading...

Member takes

Overview

Observational study reveals cytokine storm management with corticosteroids impacts ICU mortality rates in COVID-19 patients.

Key Points

  • Higher doses of corticosteroids resulted in more favorable clinical outcomes in ICU patients with COVID-19.
  • The study analyzed data showing a 28-day ICU mortality rate of 55.97% among those treated with corticosteroids.
  • Patients receiving Methylprednisolone had a lower shock index compared to those on Dexamethasone.
  • The observational analysis covered patients admitted between March 2020 and September 2021 in MVICUs.

Cite This Study

Hasan et al. (2022) studied this question.

synapsesocial.com/papers/68d4768331b076d99fa6f116https://doi.org/10.47310/iarjacc.2022.v03i01.049
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Methylprednisolone pulse therapy compared with intravenous dexamethasone for severe COVID-19 patients: a randomized clinical trial2025
  2. 2A Comparative Study of Dexamethasone and Methylprednisolone in COVID-19 Patients: Clinical Outcomes and Inflammatory Markers2024
  3. 3Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study2024 · 3 citations
  4. 4Efficacy of Low-dose vs High-dose Pulse Therapy of Methylprednisolone on Selected Clinical Outcomes among Moderate to Severe COVID-19 Patients: A Retrospective Observational Study from Intensive Care Units2026
  5. 5The impact of different corticosteroids in hospitalised patients with severe COVID-19 pneumonia: a retrospective observational study2024